A Comparative Study of Entecavir vs. Adefovir Plus Lamivudine vs Combination Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study.
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Entecavir (Primary) ; Lamivudine; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms DEFINE
- 31 Aug 2018 Biomarkers information updated
- 10 Nov 2012 Status changed from active, no longer recruiting to completed.
- 03 Jul 2012 Actual patient number is 629 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History